Cardinal Health (NYSE: CAH) announced today that its board has elected CFO Jason Hollar to become the pharma and medtech giant’s new chief executive officer, effective Sept. 1. Hollar will succeed Mike Kaufmann, who has been Dublin, Ohio–based Cardinal Health’s CEO for the past five years. The CEO transition comes as Cardinal Health continues efforts […]
The 10 largest orthopedic device companies in the world
Stryker, Johnson & Johnson’s DePuy Synthes and Zimmer Biomet are the largest orthopedic device companies. With elective procedure numbers rebounding after the darkest days of the COVID-19 pandemic, sales at most of the world’s largest orthopedic device companies increased by double-digit percentages during their most recent fiscal years. Here are the world’s 10 largest orthopedic […]
Alcon lowers its 2022 forecast amid strong dollar
Alcon (SIX/NYSE:ALC) posted Street-beating second quarter results but lowered its 2022 guidance amid a challenging macroeconomic environment. The Geneva-based eye care tech giant announced yesterday evening that it earned $148 million, or 30¢ per share, off $2.22 billion in sales during the quarter ended June 30, 2022, for a bottom-line decline of 2% and a […]
Butterfly Network asks judge to dismiss Fujifilm Sonosite IP suit
Butterfly Network (NYSE: BFLY) announced today that it asked a federal judge in Delaware to dismiss Fujifilm Sonosite’s patent infringement lawsuit against the handheld ultrasound creator. Fujifilm Sonosite (Bothell, Washington) filed the lawsuit in the U.S. District Court for the District of Delaware in March. The suit claims infringement of seven patents (U.S. Patent Nos. […]
Stereotaxis stock down amid cloudy outlook
Stereotaxis (NYSE: STXS) today reported second-quarter revenue that missed Wall Street projections, with the surgical robotics company unable to say how quickly revenue will pick up. Investors reacted by sending STXS shares down more than 18% to $2.10 apiece by late afternoon trading today. The St. Louis–based company lost $5.1 million, or 7¢ per share, […]
Vicarious Surgical completes Beta 2 system design
Vicarious Surgical (NYSE:RBOT) continues to progress in the development of its Beta 2 robotic surgery platform, though supply chain disruption poses risks for the company’s timeline. That appeared to be the big message out of the Waltham, Massachusetts–based surgical robotics company’s Q2 earnings report yesterday evening. Vicarious Surgical’s technology uses proprietary human-like surgical robots combined […]
Asensus Surgical says procedures up by more than a third in Q2
Asensus Surgical (NYSE American: ASXC) today announced mixed Q2 results that also included 34% procedures growth year-over-year. The Research Triangle Park, North Carolina–based surgical robotics and digital surgery company lost $19.6 million, or 8¢ per share, off $994,000 in revenue for the quarter ended June 20, 2022 — versus a loss of $13.2 million, or […]
MRI pioneer Dr. Raymond Damadian dies at 86
Dr. Raymond Damadian — who led a team in the 1970s that created the world’s first MRI scanner — passed away last week. Melville, New York–based Fonar Corp. — the company he founded and chaired — confirmed the Aug. 3 death in a recent news release. Damadian was 86. Fonar sold its first MRI scanner […]
BD makes tender offers for up to $500M of its debt
BD (NYSE:BDX) announced today that it has commenced tender offers to use cash to buy up to $500 million in debt securities from their holders. The move comes nearly five months after BD said it was making tender offers for notes worth up to $200 million. Just last week, BD released Q3 results that beat […]
Internal investigation continues at Dentsply Sirona
The Dentsply Sirona (Nasdaq:XRAY) board’s audit committee continues to work with independent counsel and advisors to investigate potentially questionable financial practices. The Charlotte, North Carolina–based dental products and technologies company announced yesterday that it is still unable to file official quarterly reports. It’s notified the Nasdaq markets that it cannot meet a previously agreed upon […]
Does Asensus Surgical have a Russia problem?
Add the Russia-Ukraine war to the potential challenges facing Asensus Surgical (NYSE American: ASXC) as it seeks to innovate in the surgical robotics space. Research Triangle Park, North Carolina–based Asensus today announced the sale of one of its Senhance surgical systems, an important development given that its 2021 annual report lists a total of two […]